Autoimmune haemolytic anaemia associated with mantle cell lymphoma

International Journal of Hematology

Volumn 91, Issue 2, 2010, Pages 322-325

  Eve, Heather E ^a   Rule, Simon A J ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Autoimmune haemolysis; Mantle cell lymphoma

Indexed keywords

CHLORAMBUCIL; LOW MOLECULAR WEIGHT HEPARIN; MITOXANTRONE; PREDNISOLONE;

AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TRANSFUSION; CANCER GROWTH; CANCER REGRESSION; CASE REPORT; CHEMOTHERAPY; DISEASE CONTROL; DISEASE PREDISPOSITION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MANTLE CELL LYMPHOMA; MULTIPLE CYCLE TREATMENT;

AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD TRANSFUSION; FEMALE; GLUCOCORTICOIDS; HEMOGLOBINS; HUMANS; LYMPHOMA, MANTLE-CELL; PREDNISOLONE; REMISSION INDUCTION;

EID: 77950918497     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0489-9     Document Type: Article

References (13)

1. F Mauro R Foa R Cerretti D Giannarelli S Coluzzi F Mandelli, et al. 2000 Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features Blood 95 2786 2792 1:CAS:528: DC%2BD3cXivVarurY%3D 10779422 (Pubitemid 30235886)
2. A Hauswirth C Skrabs C Schützinger A Gaiger K Lechner U Jäger 2007 Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas Leuk Lymph 48 1139 1149 10.1080/10428190701385173 (Pubitemid 47009204)
3. P Martin A Chadburn P Christos K Weil RR Furman J Ruan, et al. 2009 Outcome of deferred initial therapy in mantle-cell lymphoma J Clin Oncol 27 1209 1213 10.1200/JCO.2008.19.6121 19188674
4. Eve HE, Furtado MV, Hamon MD, Rule SAJ. Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma. J Clin Oncol. 2009 [Epub ahead of print].
5. Y Kawachi M Ide T Uchida K Setsu 2003 Idiopathic thrombocytopenic purpura associated with mantle cell lymphoma showing an increase in the platelet count receiving anti-CD20 antibody rituximab Rinsho Ketsueki 44 31 33 12649836
6. B Garvey 2008 Rituximab in the treatment of autoimmune haematological disorders Br J Haematol 141 149 169 10.1111/j.1365-2141.2008.07054.x 1:CAS:528:DC%2BD1cXlsV2muro%3D 18318765 (Pubitemid 351406218)
7. A Hara T Wada S Kitajima T Toyama T Okumura K Kitagawa, et al. 2008 Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies Am J Hematol 83 750 752 10.1002/ajh.21241 1:CAS:528:DC%2BD1cXhtF2qsr7P 18626921
8. S Assimakopoulos S Michalopoulou M Melachrinou N Giannakoulas C Papakonstantinou A Lekkou, et al. 2007 Primary Sjögren syndrome complicated by autoimmune hemolytic anaemia and pure red cell aplasia Am J Med Sci 334 493 496 10.1097/MAJ.0b013e318068b5fd 18091373 (Pubitemid 350306470)
9. H Katayama M Takeuchi T Yoshino M Munemasa A Tada R Soda, et al. 2001 Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anaemia and pure red cell aplasia Leuk Lymph 42 539 542 10.3109/10428190109064614 1:STN:280:DC%2BD3Mnks1Ojtg%3D%3D (Pubitemid 32725613)
10. A Zeidman Z Fradin Y Barac D Bendayan M Mittelman J Orlin 2000 Splenic lymphoma presenting as warm autoimmune haemolytic anemia associated with pure red cell aplasia Vox Sang 78 126 129 10.1046/j.1423-0410.2000.7820126.x 1:STN:280:DC%2BD3c3jtVSruw%3D%3D 10765150 (Pubitemid 30166949)
11. P Rossi A Demoux B Granel D Bagnères S Bonin-Guillaume Y Frances 2005 Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathy Rheumatology 44 403 405 10.1093/rheumatology/keh463 1:CAS:528: DC%2BD2MXhslSlu7Y%3D 15637040 (Pubitemid 40361304)
12. M Lande G Thomas D Houghton 2001 Membranous nephropathy associated with chronic immune thrombocytopenia purpura in childhood Am J Kidney Dis 37 E40 10.1016/S0272-6386(05)90004-8 1:STN:280:DC%2BD3MrlsFCitQ%3D%3D 11325705
13. J Thachil 2008 Autoimmune haemolytic anaemia-an under-recognized risk factor for venous thromboembolism Transfus Med 18 377 378 10.1111/j.1365-3148. 2008.00890.x 1:STN:280:DC%2BD1M%2FmvFShsA%3D%3D 19140822